Purchase Order 75N92022P00212
Award Date 7/20/23
Potential Completion Date 7/20/23
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,240,000.00 firm fixed price definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lumiradx, Inc., a foreign-owned, for-profit organization. The contract is for Lumiradx to provide a SARS-CoV-2 & Flu A/B high sensitivity antigen assay under the RADX Tech program. The contract has an ultimate completion date of May 31, 2022 and was awarded on September 30, 2021. This contract is not associated with any set-aside designation.
- <p>This is a $22,570,000.00 firm fixed price definitive contract awarded to Flambeau Diagnostics LLC by the National Heart Lung and Blood Institute, a civilian agency, for the development of RADX TECH 2375 - Point of Need, Saliva-Based, COVID-19 Testing Platforms. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation. This contract is not associated with a larger contract vehicle.</p>
- This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price Purchase Order to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the maintenance and service of the ImageStream Mk II system and has a completion date of September 29, 2026 with a potential value of $185,873.60. This contract does not have a set-aside designation. Luminex provides proprietary...
- This is a $74,968.00 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the delivery of diagnostic products and services, with a period of performance through April 30, 2026. Luminex holds several significant federal contract vehicles, including a $250,000 single-award indefinite delivery contract (IDC) with the U.S. Department of Agriculture (USDA)...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Luminex Corp, a manufacturer of biological testing technologies and diagnostic solutions. The $88,600 contract is for the provision of Luminex test kits and reagents to support the U.S. Air Force School of Aerospace Medicine (USAFSAM/PH). The contract has an ultimate completion date of October 15, 2024 and was awarded on September 30, 2024. This purchase order is not a set-aside contract. Luminex Corp is a...
- This is a firm fixed-price purchase order awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies headquartered in Austin, Texas. The $624,206.10 contract is for the delivery of COVID-19 LUMINEX NXTAG Respiratory Pathogens Panel Kits, which are multiplex diagnostic test kits used to detect various respiratory pathogens, including SARS-CoV-2. This...
- This is a $6,327.95 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Luminex Corporation, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for the delivery of unspecified products or services, and does not have a set-aside designation. Luminex holds several significant federal contract vehicles, including a $250,000 single-award indefinite delivery...
- This is a $36,972.00 delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Luminex Corp, a foreign-owned, for-profit manufacturer of biomedical diagnostic technologies based in Austin, Texas. The contract is for the delivery of NXTAG Respiratory Pathogen Panels (RPP) and has a completion date of February 5, 2025. The contract is a firm fixed-price award without any small business set-aside designations. Luminex holds several significant federal...
- This is a $82,472 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the delivery of unspecified test kits, with a period of performance running through September 30, 2025. No set-aside designation is indicated. Luminex is a foreign-owned, for-profit organization that provides proprietary multiplexing platforms,...
This is a $146,030 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian federal agency, to LumiraDx, Inc., a for-profit foreign-owned company located in Waltham, Massachusetts. The award is for the finalization of a SARS-CoV-2 and influenza A/B test under the RADX TECH program. The contract has an ultimate completion date of July 20, 2023 and does not have a set-aside designation.
Generated 6/29/25, 1:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($97k) | 6/24/25 | |
| P00001 | Other Administrative Action | $0 | 6/13/23 | |
| Not listed | Not listed | $243.0k | 7/20/22 |